Van Eck Associates Corp Bristol Myers Squibb CO Transaction History
Van Eck Associates Corp
- $88.3 Billion
- Q2 2025
A detailed history of Van Eck Associates Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Van Eck Associates Corp holds 3,926,110 shares of BMY stock, worth $170 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
3,926,110
Previous 4,993,118
21.37%
Holding current value
$170 Million
Previous $305 Million
40.32%
% of portfolio
0.21%
Previous 0.39%
Shares
33 transactions
Others Institutions Holding BMY
# of Institutions
2,668Shares Held
1.64BCall Options Held
22.4MPut Options Held
25.3M-
Vanguard Group Inc Valley Forge, PA195MShares$8.46 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$6.88 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.69 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.11 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.07 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $92.3B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...